Clinical Trial Update: Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial [Phase 2]

View source ↗

Summary

A Phase 2 trial update on chemoradiation with Avastin (bevacizumab), capecitabine, and oxaliplatin for locally advanced and low rectal cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Advanced Colorectal Cancer | Phase 2 | Status: COMPLETED